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Regarding “Isolation of endothelial cells and their
progenitor cells from human peripheral blood”
We are writing in regard to your published article “Isolation
of endothelial cells and their progenitor cells from human periph-
eral blood” (J Vasc Surg 2000;31:181-9).
We read with interest Boyer et al’s article in Journal of
Vascular Surgery.1 We have been evaluating endothelial cell
extraction from many sources and seeding of vascular prosthesis
for many years; therefore, we investigated the possibility of cell
extraction from this source. The evidence so far suggests that
endothelial seeding of prosthetic graft improves graft patency
only when the source of the endothelial cells is vein and when the
cells are cultured.2,3 The recent report by Boyer et al has
described peripheral blood as another source of endothelial cells
for seeding vascular prosthesis. These cells were extracted using
CD34+ monoclonal antibody and then require prolonged culture
for 18 days before a typical cobblestone appearance was observed.
However, in their article, Boyer et al have not mentioned the total
number of CD34+ cells extracted from the 50 mL of blood and
the purity of their CD34+ cell extraction. To gather the feasibil-
ity of this source for seeding of prosthetic graft, we undertook
extraction of CD34+ cells from peripheral blood using a com-
mercial anti-CD34+ monoclonal antibody (HPCA-2, BD,
Oxford, United Kingdom).
A 29-year-old healthy volunteer had 50 mL of blood collected
into a tube containing 100 USP sodium heparin. The initial por-
tion of the blood was discarded to avoid contamination with
mature endothelial cells from the vein wall as per the technique of
Boyer et al. The blood was then mixed with an equal volume of
Hank’s balanced salt solution (HBSS) and mononuclear cells sep-
arated by discontinuous density gradient centrifugation (400 
“g”, 30 minutes). The mononuclear cell fraction was harvested
and labeled with CD34+ FITC antibody. CD34+ve progenitor
cells and endothelial cells were isolated by immunomagnetic sepa-
ration using a paramagnetic microbead conjugated to an anti-
FITC antibody (MACS VS, Miltentyi Biotec, Cologne, Germany).
The total number of mononuclear cells extracted using this
method was 61  106 (1.22  106/mL of blood). The total num-
ber of cells extracted using the immunomagnetic separation sys-
tem was 0.5  106 cells for 50 mL of blood. The purity of this
sample was 6.45%, so the total number of CD34+ cells was
32,250 cells, ie, 3.2  104 cells per 50 mL of blood (645
cells/mL).
In our experiment, we extracted 10 times more mononuclear
cells than Boyer et al did. However, our total number of pure
CD34+ cells was only 3.2  104 cells. Even if the purity were
15.7% as shown by Asahara et al,4 then the total number of cells
extracted would still be only 7.85  104 cells. This does not con-
stitute a large number of cells, which can be used for single stage
seeding, such as that required for polytetrafluoroethylene, where
2  105 cells per cm2 for graft are needed.5 We would also expect
the number of cells that can be extracted in an older patient to be
less and more likely to fail in culture.6 Regarding the two stage
seeding, we believe that an easier and proven source is vein allow-
ing up to 5.2  105 cells to be extracted from the external jugu-
lar vein.3,7 The endothelial cells from vein are easily cultured,
allowing a large number of cells to be available within 26 days.8
We would therefore conclude that the inadequate number of cells
that are extracted from peripheral blood and the prolonged cul-
ture required for them to differentiate into endothelial cells do
not allow their current use as a suitable source for seeding of
grafts for use in humans.
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We thank Dr Tiwari and colleagues for their interest in our
article and for the comparison of their data with ours. In the
experiments with adult peripheral blood, we were able to grow
large numbers of cells, enough for seeding of a graft as we
described on page 185, by placing the mononuclear cells, isolated
from a Ficoll gradient, into endothelial cell growth medium + calf
serum with iron. This was described as the best medium (Table I)
for umbilical cord blood; it was also best for adult peripheral
blood. The medium is permissive for endothelial cell development
and proliferation; other cells eventually lifted off the culture dish
or died, as did the initial cells exhibiting vasculogenesis. The
endothelial cells were not evident until most of the mononuclear
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cells and progenitor cells exhibiting vasculogenesis had died.
These endothelial cells were then transduced with the gene for
prourokinase and seeded onto expanded polytetrafluoroethylene
graft material followed by testing for adherence as described in
the article. Thus, we were able to obtain sufficient cells, not only
for seeding, but transduction before seeding.
Cells that were exposed to magnetic beads in the process of
isolation were not suitable for cell expansion because they phago-
cytosed some of the magnetic beads, so proliferation was too slow.
We also found that too few cells were isolated by the magnetic-
bead method to make this a feasible method for seeding grafts.
Upon checking our original data, we discovered that we iso-
lated 1.52 ± 0.43  106 mononuclear cells per mL of peripheral
blood, which is comparable to what Dr Tiwari and colleagues
obtained. On page 185 we reported that tenfold fewer cells were
isolated, a computational mistake. In a separate publication1 we
reported approximately the same values as Dr Tiwari and col-
leagues. In this same publication, we further describe isolation
and proliferation of cells from adult peripheral blood. In addition,
we have completed studies with a series of dogs having carotid
artery grafts seeded with jugular vein endothelial cells on one side
and peripheral blood stem cell derived endothelial cells on the
other side, harvested at 1- and 6-month intervals, which show no
difference in patency whether seeded with jugular vein endothe-
lial cells or peripheral blood stem cell derived endothelial cells.2,3
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Regarding “Bedside vena cava filter placement guided
with intravascular ultrasound”
We wish to commend the authors for their work in develop-
ment of intravascular ultrasound (IVUS) guided delivery of infe-
rior vena cava (IVC) filters at the patient’s bedside (J Vasc Surg
2001;34:21-6). In the intensive care setting, a small proportion of
patients cannot be transported safely to the interventional radiol-
ogy suite for conventional fluoroscopically guided IVC filter place-
ment. At our institution, this usually involves patients with closed
head injuries and elevated intracranial pressure that compromises
cerebral perfusion when the patient is placed supine. For the read-
ership without access to or experience with IVUS but who have
portable fluoroscopy and cooperative interventional radiologists,
we would like to point out a technique for bedside placement of
IVC filters developed at the University of California, San Diego.1
Transcutaneous duplex ultrasound scanning is used to assess the
internal jugular and common femoral veins bilaterally to plan
venous access and the IVC to obtain diameter measurements for
specific filter selection. Portable fluoroscopy with digital subtrac-
tion angiographic capability is used to perform transcatheter con-
trast inferior vena cavography and bilateral renal venography to
confirm IVC diameter measurements and to evaluate for possible
renal vein and IVC anatomic variants that would alter filter place-
ment. Real-time fluoroscopy is used to guide device manipulation
and assess adequacy of filter placement after deployment.
We do not believe that bedside IVC filter placement is appro-
priate in patients without strong contraindications to transport to
the interventional radiology suite. The financial arguments based
on differential hospital charges for bedside IVC filter placement
are irrelevant given our current reimbursement environment.
Tradeoffs for bedside IVC filter placement can be considerable. In
the case of bedside IVC filter placement, breaches in the sterile
field are more likely (eg, a guidewire touching objects outside the
improvised sterile field), inventory is limited if difficulty is
encountered or items are dropped, the gold standard technique
of contrast venography is not used for identifying IVC and renal
vein variant anatomy that may alter the placement of the filter is
not used,2 and there is no mechanism for identifying, much less
correcting, maldeployed filters (eg, excessive tilt, asymmetric leg
deployment, or overlapping filter struts).3,4
In summary, we believe that bedside IVC filter placement is
a valuable alternative for these few patients with prohibitive risks
for transport, but it is a suboptimal technique for most patients.
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We would like to thank Drs Rose, Kinney, and Valji for their
comments, and we generally concur with their views, although
some points should be clarified.
Specific indications for this technique continue to undergo
refinement since this feasibility study. All patients in the research
study have contraindications to transport, such as an unstable
spine, continuous hemofiltration, hemodynamic instability, or
hypothermia. Patients who are not in intensive care were
